{"id":15440,"date":"2024-09-16T12:37:28","date_gmt":"2024-09-16T12:37:28","guid":{"rendered":"https:\/\/rtl.ee\/uncategorized\/07-11-2024-conference-baltic-regulatory-affairs-virtual-conference-2024-epi-today-and-tomorrow-challenges-opportunities-and-benefits\/"},"modified":"2024-11-04T14:39:37","modified_gmt":"2024-11-04T14:39:37","slug":"07-11-2024-conference-baltic-regulatory-affairs-virtual-conference-2024-epi-today-and-tomorrow-challenges-opportunities-and-benefits","status":"publish","type":"post","link":"https:\/\/rtl.ee\/en\/uudised-en\/07-11-2024-conference-baltic-regulatory-affairs-virtual-conference-2024-epi-today-and-tomorrow-challenges-opportunities-and-benefits\/","title":{"rendered":"07.11.2024 Conference: &#8220;Baltic Regulatory Affairs Virtual Conference 2024. ePI Today and Tomorrow: Challenges, Opportunities and Benefits&#8221;"},"content":{"rendered":"<div id=\"cmsmasters_row_8y917xngek\" class=\"cmsmasters_row cmsmasters_color_scheme_default cmsmasters_row_top_default cmsmasters_row_bot_default cmsmasters_row_boxed\">\n<div class=\"cmsmasters_row_outer_parent\">\n<div class=\"cmsmasters_row_outer\">\n<div class=\"cmsmasters_row_inner\">\n<div class=\"cmsmasters_row_margin\">\n<div id=\"cmsmasters_column_k7mfj66ge4\" class=\"cmsmasters_column one_first\">\n<div class=\"cmsmasters_column_inner\"><div class=\"cmsmasters_embed_wrap\">\n<iframe loading=\"lazy\" title=\"Baltic Regulatory Affairs Virtual Conference 2024\" width=\"1160\" height=\"653\" src=\"https:\/\/www.youtube.com\/embed\/xtv1D39PBDk?feature=oembed&enablejsapi=1&origin=https:\/\/rtl.ee\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"cmsmasters_row_r3o78m6jmb\" class=\"cmsmasters_row cmsmasters_color_scheme_default cmsmasters_row_top_default cmsmasters_row_bot_default cmsmasters_row_boxed\">\n<div class=\"cmsmasters_row_outer_parent\">\n<div class=\"cmsmasters_row_outer\">\n<div class=\"cmsmasters_row_inner\">\n<div class=\"cmsmasters_row_margin\">\n<div id=\"cmsmasters_column_i8p0x1q6gp\" class=\"cmsmasters_column one_first\">\n<div class=\"cmsmasters_column_inner\"><div class=\"cmsmasters_text\">\n<p>It is our great pleasure to invite you to participate at the <span style=\"color: #3065b5;\"><strong>&#8220;Baltic Regulatory Affairs Virtual Conference 2024. ePI Today and Tomorrow: Challenges, Opportunities and Benefits&#8221;<\/strong><\/span> on the <strong><span style=\"color: #3065b5;\">7th of November 2024 at 10.00-15.15 EET (9.00-14.15 CET).<\/span><\/strong><\/p>\n<p><!--more--><\/p>\n<\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"cmsmasters_row_aiecbqnrzd\" class=\"cmsmasters_row cmsmasters_color_scheme_default cmsmasters_row_top_default cmsmasters_row_bot_default cmsmasters_row_boxed\">\n<div class=\"cmsmasters_row_outer_parent\">\n<div class=\"cmsmasters_row_outer\">\n<div class=\"cmsmasters_row_inner cmsmasters_row_no_margin\">\n<div class=\"cmsmasters_row_margin\">\n<div id=\"cmsmasters_column_hg1ui4aq5m\" class=\"cmsmasters_column one_first\">\n<div class=\"cmsmasters_column_inner\"><div id=\"cmsmasters_heading_vsgtibfkfa\" class=\"cmsmasters_heading_wrap cmsmasters_heading_align_left\">\n\t<h2 class=\"cmsmasters_heading\">AGENDA<\/h2>\n<\/div><div id=\"cmsmasters_heading_v6o7x2845e\" class=\"cmsmasters_heading_wrap cmsmasters_heading_align_left\">\n\t<h2 class=\"cmsmasters_heading\">Session I<\/h2>\n<\/div><div class=\"cmsmasters_wrap_table\"><table class=\"cmsmasters_table\"><caption><\/caption><thead><tr class=\"cmsmasters_table_row_header\"><th class=\"cmsmasters_table_cell_alignleft\">Time<\/th><th class=\"cmsmasters_table_cell_alignleft\">Title<\/th><th class=\"cmsmasters_table_cell_alignleft\">Lecturer<\/th><\/tr><\/thead><tr><td class=\"cmsmasters_table_cell_alignleft\">10.00\u201310.10<\/td><td class=\"cmsmasters_table_cell_alignleft\">Welcoming Words from the Moderator<\/td><td class=\"cmsmasters_table_cell_alignleft\">Kristin Parts, SpeakSmart<\/td><\/tr><tr><td class=\"cmsmasters_table_cell_alignleft\">10.10\u201310.20 <\/td><td class=\"cmsmasters_table_cell_alignleft\">Opening Address<\/td><td class=\"cmsmasters_table_cell_alignleft\">Heleni M\u00e4e, Legal Advisor, Estonian State Agency of Medicines<\/td><\/tr><tr><td class=\"cmsmasters_table_cell_alignleft\">10.20\u201310.50 <\/td><td class=\"cmsmasters_table_cell_alignleft\">EFPIA Views on How to Future-proof the EU General Pharmaceutical Legislation &#8211; What Roles Does the Electronic Product Information Play?<\/td><td class=\"cmsmasters_table_cell_alignleft\">Sini Eskola, Director Regulatory Strategy, EFPIA<\/td><\/tr><tr><td class=\"cmsmasters_table_cell_alignleft\">10.50\u201311.20 <\/td><td class=\"cmsmasters_table_cell_alignleft\">ePI for Human Medicines in the EU by EMA \u2013 a Look into the Future<\/td><td class=\"cmsmasters_table_cell_alignleft\">Dr Juan Garcia Burgos, Head of Public and Stakeholders Engagement Department, EMA and Elizabeth Scanlan, Scientific Communication Officer &amp; ePI Product Owner, EMA<\/td><\/tr><tr><td class=\"cmsmasters_table_cell_alignleft\">11.20\u201311.50 <\/td><td class=\"cmsmasters_table_cell_alignleft\">ePI for Human Medicines in the EU by EMA \u2013 Piloting Experience from the Netherlands<\/td><td class=\"cmsmasters_table_cell_alignleft\">Astrid Kragt, RA Senior Manager, Novartis NL<\/td><\/tr><tr><td class=\"cmsmasters_table_cell_alignleft\">11.50-12.15<\/td><td class=\"cmsmasters_table_cell_alignleft\">Gravitate Health ePI Project: Progress and Achievements<\/td><td class=\"cmsmasters_table_cell_alignleft\">Anne Moen, Gravitate Health<\/td><\/tr><tr><td class=\"cmsmasters_table_cell_alignleft\">12.15\u201312.20 <\/td><td class=\"cmsmasters_table_cell_alignleft\">QA<\/td><td class=\"cmsmasters_table_cell_alignleft\"><\/td><\/tr><tr><td class=\"cmsmasters_table_cell_alignleft\">12.20-13.00 <\/td><td class=\"cmsmasters_table_cell_alignleft\">Lunch break<\/td><td class=\"cmsmasters_table_cell_alignleft\"><\/td><\/tr><\/table><\/div><div id=\"cmsmasters_heading_xfwzi1qech\" class=\"cmsmasters_heading_wrap cmsmasters_heading_align_left\">\n\t<h2 class=\"cmsmasters_heading\">Session II<\/h2>\n<\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n<div class=\"cmsmasters_row_inner cmsmasters_row_fullwidth cmsmasters_row_no_margin\">\n<div class=\"cmsmasters_row_margin\">\n<div id=\"cmsmasters_column_z7hpvbcdd\" class=\"cmsmasters_column one_first\">\n<div class=\"cmsmasters_column_inner\"><div class=\"cmsmasters_wrap_table\"><table class=\"cmsmasters_table\"><caption><\/caption><thead><tr class=\"cmsmasters_table_row_header\"><th class=\"cmsmasters_table_cell_alignleft\">Time<\/th><th class=\"cmsmasters_table_cell_alignleft\">Title<\/th><th class=\"cmsmasters_table_cell_alignleft\">Lecturer<\/th><\/tr><\/thead><tr><td class=\"cmsmasters_table_cell_alignleft\">13.00 \u2013 13.25 <\/td><td class=\"cmsmasters_table_cell_alignleft\">Norwegian Experience: Building Public Awareness on ePI &#8211; Paving the Way for the Future<\/td><td class=\"cmsmasters_table_cell_alignleft\">Dag R. Jordbru, Strategic Director, Norwegian Medical Products Agency (NOMA)<\/td><\/tr><tr><td class=\"cmsmasters_table_cell_alignleft\">13.25 \u2013 13.50 <\/td><td class=\"cmsmasters_table_cell_alignleft\">Spanish Experience: ePIL at the Health Authority\u2019s Website<\/td><td class=\"cmsmasters_table_cell_alignleft\">Evinn Drusys, ePI co-Product Owner, AEMPS<\/td><\/tr><tr><td class=\"cmsmasters_table_cell_alignleft\">13.50 \u2013 14.15 <\/td><td class=\"cmsmasters_table_cell_alignleft\">Development and Use of ePI in Spain \u2013 AEMPS CIMA, Industry View<\/td><td class=\"cmsmasters_table_cell_alignleft\">Ana Medina Guerrero, Farmaindustria<\/td><\/tr><tr><td class=\"cmsmasters_table_cell_alignleft\">14.15 \u2013 14.40 <\/td><td class=\"cmsmasters_table_cell_alignleft\">Results of a Survey in Estonia on Attitudes Towards Packages Without Paper PIL and Readiness to Use ePIL<\/td><td class=\"cmsmasters_table_cell_alignleft\">Aet Raukas, RA Team Lead, Novartis EE<\/td><\/tr><tr><td class=\"cmsmasters_table_cell_alignleft\">14.40 \u2013 15.05 <\/td><td class=\"cmsmasters_table_cell_alignleft\"> Dialogue with a Patient <\/td><td class=\"cmsmasters_table_cell_alignleft\">Janek Kapper, Estonian Chamber of Disabled People and Kristin Parts, SpeakSmart <\/td><\/tr><tr><td class=\"cmsmasters_table_cell_alignleft\">15.05 \u2013 15.10 <\/td><td class=\"cmsmasters_table_cell_alignleft\">QA<\/td><td class=\"cmsmasters_table_cell_alignleft\"><\/td><\/tr><tr><td class=\"cmsmasters_table_cell_alignleft\">15.10 \u2013 15.15 <\/td><td class=\"cmsmasters_table_cell_alignleft\">Final words<\/td><td class=\"cmsmasters_table_cell_alignleft\"><\/td><\/tr><\/table><\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n<div class=\"cmsmasters_row_inner\">\n<div class=\"cmsmasters_row_margin\">\n<div id=\"cmsmasters_column_373smrjzmf\" class=\"cmsmasters_column one_first\">\n<div class=\"cmsmasters_column_inner\"><div class=\"cmsmasters_text\">\n<p><span style=\"color: #3065b5;\"><strong>Organizing team, Estonia:<\/strong><\/span><\/p>\n<ul>\n<li>Aet Raukas, Novartis<\/li>\n<li>Iivi Ammon, Bayer<\/li>\n<li>Kairit Karbus, AbbVie<\/li>\n<li>Merit Aava, Novartis<\/li>\n<li>Piret Metsala, Association of Pharmaceutical Manufacturers in Estonia<\/li>\n<li>Moderator Kristin Parts, SpeakSmart<\/li>\n<li>Sirli Peepson, Association of Pharmaceutical Manufacturers in Estonia, Contact:\u00a0<a href=\"mailto:sirli.peepson@rtl.ee\">sirli.peepson@rtl.ee<\/a>, +372 5566 4868<\/li>\n<\/ul>\n<\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n","protected":false},"excerpt":{"rendered":"<p>It is our great pleasure to invite you to participate at the &#8220;Baltic Regulatory Affairs Virtual Conference 2024. ePI Today and Tomorrow: Challenges, Opportunities and Benefits&#8221; on the 7th of November 2024 at 10.00-15.15 EET (9.00-14.15 CET).<\/p>\n","protected":false},"author":2,"featured_media":15391,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","footnotes":""},"categories":[81],"tags":[],"class_list":["post-15440","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uudised-en"],"_links":{"self":[{"href":"https:\/\/rtl.ee\/en\/wp-json\/wp\/v2\/posts\/15440","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rtl.ee\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rtl.ee\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rtl.ee\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/rtl.ee\/en\/wp-json\/wp\/v2\/comments?post=15440"}],"version-history":[{"count":2,"href":"https:\/\/rtl.ee\/en\/wp-json\/wp\/v2\/posts\/15440\/revisions"}],"predecessor-version":[{"id":15452,"href":"https:\/\/rtl.ee\/en\/wp-json\/wp\/v2\/posts\/15440\/revisions\/15452"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rtl.ee\/en\/wp-json\/wp\/v2\/media\/15391"}],"wp:attachment":[{"href":"https:\/\/rtl.ee\/en\/wp-json\/wp\/v2\/media?parent=15440"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rtl.ee\/en\/wp-json\/wp\/v2\/categories?post=15440"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rtl.ee\/en\/wp-json\/wp\/v2\/tags?post=15440"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}